Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-01-30
2007-01-30
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S046000, C514S047000, C514S048000, C514S049000, C514S050000, C514S051000, C514S917000
Reexamination Certificate
active
09494243
ABSTRACT:
The invention relates to compositions comprising acyl derivatives of 2′-deoxyribonucleosides. The invention also relates to methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, and methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.
REFERENCES:
patent: 3585188 (1971-06-01), Marumoto et al.
patent: 3856776 (1974-12-01), Cehovic
patent: 3860706 (1975-01-01), Ikeda
patent: 3894000 (1975-07-01), Wechter et al.
patent: 3975367 (1976-08-01), Gish et al.
patent: 3991045 (1976-11-01), Ishida
patent: 4048432 (1977-09-01), Baker
patent: 4208406 (1980-06-01), Lapinet
patent: 4560678 (1985-12-01), Ranson
patent: 4657896 (1987-04-01), Yano
patent: 4675189 (1987-06-01), Kent et al.
patent: 4757139 (1988-07-01), Kawaguchi
patent: 4758553 (1988-07-01), Ogoshi
patent: 4868162 (1989-09-01), Kawaguchi
patent: 5246708 (1993-09-01), von Borstel et al.
patent: 6020322 (2000-02-01), von Borstel et al.
patent: 1941942 (1971-03-01), None
patent: 3319282 (1983-11-01), None
patent: 0222192 (1987-05-01), None
patent: 835941 (1964-11-01), None
patent: AL 2556727 (1985-06-01), None
patent: 2152814 (1984-12-01), None
patent: 2023085 (1977-02-01), None
patent: 57-091995 (1982-06-01), None
patent: 5849315 (1983-03-01), None
patent: 58-167598 (1983-10-01), None
patent: 60-0028929 (1985-02-01), None
patent: 60-064907 (1985-04-01), None
Martin et al, J. of Pharmaceutical Sciences, vol. 76, No. 2, pp. 180-184 (1987).
Kanazir et al, Bull. Inst. Nuc. Sci. “Boris, Kidrich” 9:145-153 (1959).
Beltz et al, Bioch. Biophys. Acta, vol. 297, pp. 258-267 (1973).
Hunting, D.J.. et al, Carcinogenesis, vol. 6, pp. 1525-1528 (1985).
Golba, et al, Int. J. Rad. Biol. 13:261-268 (1967).
Goh et al, Proc. Soc. Exp. Biol. Med. 145:938-943 (1974).
Horikawa et al, Exp. Cell Res. 34:198-200 (1964).
Pantic et al, Nature 193:993-994 (1962).
Paoletti et al, Rev. Francais, Etudes Clin. et Bio. 9:950-955 (1964).
Petrovic et al, Int. J. Radiat. Biol. 18:243-258 (1970).
Petrovic et al, Studia Biophysica 43:13-18 (1974).
Petrovic et al, Int. J. Radiat. Res. 11:609-611 (1967).
Savkovic et al, Nature 203:1297-1298 (1964).
Savkovic et al, Nature 211:1179-1180 (1966).
Savkovic et al, Int. J. Rad. Biol. 9:361-368 (1965).
Smets et al, Int. J. Rad. Biol. 13:269-273 (1967).
Soska et al, Folia Biologica 5:190-198 (1959).
Sugahara et al, Brookhaven Symposia in Biology, 284-302 (1967).
Wagner, Int. J. Rad. Biol. 12:101-112 (1967).
Wilczok et al, Int. J. Rad. Biol. 9:201-211 (1965).
Goyanes-Villaescusa et al, Lancet 2:575-576 (1973).
Dumont, Ann. Surg. 150:799-807 (1959).
Nicolau et al, Der Hautarzt, 17:512-515 (1966).
Marshak et al, Proc. Soc. Exp. Bid. Med. 58:62-63 (1945).
Newman et al, Am. J. Physiol. 164:251-253 (1951).
Casida et al, Biochemical Pharmacology 15:627-644 (1966).
Rosowsky et al, Cancer Treatment Reports 65:93-99 (Jan./Feb. 1981).
Ensminger et al, Biochemical Pharmacology 28:1541-1545 (Oct. 1978).
Szoka, Jr. et al, (1978), Proc. Natl. Acad. Sci., vol. 75, No. 9, pp. 4194-4198.
Wechter et al, “Ara-Cytidine Acylates. Use of . . . Relationship Correlation 1,2,”, Journal of Med. Chem. 18, No. 4 (1975), pp. 339-344.
Wechter et al, Nucleic Acids. 16. Orally . . . Cybidine 1,2,,, Journal of Medicinal Chemistry, 19, No. 8 (1976), pp. 1013-1016.
DeLapp et al, “Important of Pyrimidine . . . In Skin”, J. Investigative Dermatol 66:306-312 (1976).
R.D. Snyder, “The Role of Deoxynucleoside . . . By Hydroxyurea”, Mutation Research, 131 (184), pp. 163-172.
Okabe et al, “A Method for Experimental, . . . Ulcers in Rats”, Digestive Diseases, vol. 16, No. 3 (Mar. 1971), pp. 277-283.
1988 Physician's Desk Reference, pp. 1551-1552.
Braun et al, Proc. Soc. Exptl. Biol. Med. 119:701-707 (1965).
Chemical Abstracts, vol. 74, No. 112368K, Rajabalee, Agnew. Chem. Int. Ed., Engl. 10(1):75 (1971).
Patent Abstracts of Japan, vol. 9, No. 160 (C-289)[1883], Jun. 4, 1985 (JP-A-60 034913) (Seikagaku Kogyo K.K.) Feb. 22, 1985).
Patent Abstracts of Japan, vol. 6, No. 266 (C-142)[1144], Dec. 25, 1982 (JP-A-57 156418 (Sumitomo Kagaku K.K.) Sep. 27, 1982).
Hackhs Chemical Dictionary 3rd ed. Julius Grant, ed. pp. 44, 45, 332, 333.
Ensminger et al, the Chemical Abstracts, 92: 87921x (1980).
Narang et al, the Chemical Abstracts, 83:147700a (1975).
Adamiak et al, the Chemical Abstracts, 106: 156803g (1987).
Pfleiderer, the Chemical Abstracts, 107: 218016j (1987).
Nair et al, the Chemical Abstracts, 101: 192832z (1984).
Ishido et al, the Chemical Abstracts, 92: 59149h (1980).
Fridovich, Annu. Rev. Biochem., 44:147-159 (1975).
BIOCHEMISTRY, vol. 13, No. 3, Jan. 29, 1974, pp. 553-559; M.J. Robins et al: ″3″-0-aminoacyl-2″-deoxyadenosines and 2″-0-aminoacyl-3″-deoxyadenosines related to charged transfer ribonucleic acid termini.
BIOCHEMISTRY, vol. 14, No. 14, Jul. 15, 1974, pp. 3144-3151; S.P. Dutta et al: Synthesis and properties of the naturally occurring N-[(9-beta-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt6A) and other related synthetic analogs.
BIOCHEMISTRY, vol. 20, No. 1, Jan. 6, 1981, pp. 8-15, American Chemical Society; A. Bhuta et al: “Stereochemical control of ribosomal peptidyltransferase reaction. Role of amino acid side-chain orientation of acceptor substrate”.
BIOCHEMISTRY, vol. 20, No. 12, Jun. 9, 1981, pp. 3480-3485, American Chemical Society; K. Quiggle et al: “Donor Site of Ribosomal Peptidyltransferase: Investigation of Substrate specificity using 2″(3″)-0-(N-acylaminoacyl)dinucleoside phosphates as models of the 3″terminus of N-acylaminoacyl transfer ribonucleic acid”.
Journal of American Chemical Society, vol. 104, No. 2, 1982, pp. 544-547, American Chemical Society; G. Buchi et al: “Photochemical epoxidation of aflatoxin B1 and sterigmatocystin: Synthesis of Guanine-Containing adducts”.
Pure and Applied Chemistry, vol. 52, No. 12, 1980, pp. 2705-2715, IUPAC GB; T. Matsuura et al: “Organic Chemical Approach to Photo-Cross-Links of Nucleic Acids to Proteins”.
Akman et al, Cancer Treatment Reports, 69(7-8), 851-857 (1985).
Derwent Abstract No. 91-212578 of Japanese Publication JO 3135918 (Ajinomoto) (1991).
Bamat Michael K.
Von Borstel Reid W.
Nixon & Vanderhye
Owens, Jr. Howard V.
Wellstat Therapeutics Corporation
Wilson James O.
LandOfFree
Acyl deoxyribonucleoside derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl deoxyribonucleoside derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl deoxyribonucleoside derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3778491